|
 |
CandesartanThis page contains recent news articles, when available, and an overview of Candesartan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Candesartan (when available) Candesartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, Candesartan does not have an active metabolite or possess uricosuric effects. For the treatment of hypertension. Mechanism Of Action: Candesartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance. News Articles on Candesartan Almirall launches Parapres Plus 32 and Parapres Plus Forte - Dec 16, 2009 The firm noted that the two combinations contain candesartan cylexetile, which offers high organic protection and has received support from a range of ... Zenopa pH-sensitive polymer micelles for oral delivery of drugs - Dec 21, 2009 ...block copolymers on their self-assembling properties, the loading and the release of poorly water soluble drug; candesartan cilexetil (CDN). ... Insciences Organisation 진료패턴ì?„ 바꿀 ìµœì‹ ìž„ìƒ?연구Ⅲ - Dec 27, 2009 ACEIì—? 내약성ì?´ 없는 좌심실 기능 ì €í•˜ ì‹¬ë¶€ì „ 환ìž?를 대ìƒ?으로 í•œ 'CHARM-Alternative'연구ì—?서는 칸ë?°ì‚´íƒ„(candesartan) 30mgì?´ 위약ì—? 비해 심혈관 사ë§?ê³¼ ì‹¬ë¶€ì „ ... KMA Times Blopress Plus - Nov 2, 2009 Pharmacology: Candesartan is an angiotensin II receptor antagonist, selective for AT1 receptors, with tight binding to and slow dissociation from the ... Irish Medical Times Takeda signs obesity deal with Amylin worth over $1 billion - Nov 2, 2009 Sales of the blood pressure drug Blopress (candesartan cilexetil) were down 5.8% to 112.40 billion yen, while turnover from the prostate cancer treatment ... Pharma Times EXFORGEì?˜ 효능 효과 - Nov 2, 2009 ...ì?´ëŸ° ì‹¬ë¶€ì „ 환ìž? êµ°ì—?ì„œì?˜ ARBì?˜ 효과는 CHARM-added 연구ì—?ì„œ 좀 ë?” 확ì?¸ì?´ ë?˜ì—ˆëŠ”ë?° 위약 êµ°ì—? 비해 candesartanì?„ 투여하였ì?„ ë•Œ 15%ì?˜ 위험ê°?소 효과가 있었으며 ... 코리아헬스로그 Takeda/S1: ventes en recul de 6,4% à 755 mrd JPY - Oct 30, 2009 ...-11,5% pour Lansoprazole (ulcère gastroduodénal), -5,8% pour Candesartan (hypertension) et -9% pour Leuprorelin (cancers de la prostate et du sein et ... Romandie.com HTA en pacientes con ACV - Oct 28, 2009 En él se evaluaron dos ramas: una rama placebo y otra rama con candesartan; pero solamente hicieron tratamiento placebo versus droga en la primera semana. ... Intramed.net (Suscripción) í??ê²½ 여성ì?˜ CVD risk factor 어떻게 ê´€ë¦¬í• ê²ƒì?¸ê°€? - Nov 9, 2009 ...ì?´ 연구ì—?서는 환ìž?들ì—?게 2ë…„ ë?™ì•ˆ candesartanì?„ 투여한 ê²°ê³¼ ê³ í˜ˆì•• ì „ë‹¨ê³„ 환ìž?ì—?ì„œ ê³ í˜ˆì•• 발병ì?´ ê°?소하였다. 그러나 2ë…„ì?´ 지난 후ì—?ë?„ ì—¬ì „ížˆ ì?´ë“?효과를 관찰 ... 코리아헬스로그 A Mölndal, en Suède, Astra Zeneca investit dans la lutte contre les ... - Oct 26, 2009 ...d'un partenariat avec Bristol Myers Squibb, une stratégie d'alliance qu'Astra Zeneca avait déjà appliquée avec Takeda pour le candesartan (Atacand). ... bulletins-electroniques.com Drug Slows Onset of Hypertension - Mar 15, 2006 AstraZeneca makes an ARB named candesartan, sold under the brand-name Atacand. ... In the candesartan group, 208 people had become hypertensive. ... Washington Post … the Angiotensin Receptor Blocker Candesartan in Essential Hypertensi... - Jan 25, 2007 At the completion of 6 weeks of candesartan treatment, subjects returned for a ... Systolic and diastolic BP responses to candesartan were defined as the ... Nature.com Effect of Losartan Versus Candesartan on Uric Acid, Renal Function,... - Jan 6, 2005 Correspondence: Dr. BL Rayner, E13 Groote Schuur Hospital, Observatory 7925, Cape Town, South Africa E-mail: rayner@curie.uct.ac.za ... Nature.com Does candesartan benefit patients with heart failure? - Jan 1, 2006 Demers C et al. (2005) Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. ... Nature.com … the Antiproteinuric Effect of Candesartan in Hypertensive Patients... - Apr 3, 2007 Background: We sought to compare the effect of manidipine versus hydrochlorothiazide (HCTZ) in addition to candesartan on the urinary albumin excretion rate ... Nature.com Drug Fights Diabetic Eye Disease - Sep 26, 2008 ..."We suggest that clinicians may wish to consider using candesartan [brand name Atacand] in people with type 1 diabetes with hard-to-control blood glucose, ... Washington Post Superimposing candesartan onto ACE inhibition slows renal function … - Aug 1, 2006 Kanno Y et al. (2006) Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with ... Nature.com What's the evidence for angiotensin II receptor blockers? - Jul 25, 2008 Over three years, people who took candesartan were less likely to need hospital ... Effects of candesartan in patients with chronic heart failure and ... guardian.co.uk The cost-effectiveness of candesartan-based antihypertensive treatment... - Mar 31, 2005 Since the publication of the above-mentioned article, the authors have identified an error in the first paragraph of the Methods and materials section. ... Nature.com Candesartan Increases Regression of Retinopathy in Type 2 Diabetes, … - Sep 25, 2008 NEW YORK -- September 25, 2008 -- Treatment with candesartan can increase regression of retinopathy in type 2 diabetes and reduce incidence of retinopathy ... DG News Astrazeneca says Atacand can reduce risk of diabetes in heart failure... - Jul 4, 2005 During the study period, 6 pct of patients in the candesartan group were newly diagnosed with diabetes, compared to 7.4 pct in the placebo group. ... Forbes Candesartan Cilexetil - a Review of Effects on Cardiovascular … - Aug 2, 2007 By Meredith, Peter A. Therapeutic interventions that block the renin-angiotensin- aldosterone system (RAAS) have an important role in slowing the ... RedOrbit … combo: treating 1,000 patients with candesartan avoided 1,900 days... - Apr 15, 2005 ROCKVILLE, MD. -- The angiotensin receptor blocker candesartan should be approved as a treatment for heart failure in patients who are on an ACE inhibitor, ... Free with registration - Internal Medicine News - AccessMyLibrary.com Hypertension drug likely to reduce symptoms of genetic heart disease - Dec 31, 2008 London (IANS): Candesartan, a drug currently used in treating hypertension, may significantly reduce symptoms of genetic heart disease, according to a new ... The Hindu AHA: Antihypertensive Candesartan (Atacand) Reduces Diabetes Risk - Nov 9, 2007 By Ed Susman, Contributing Writer, MedPage Today. ORLANDO, Nov. 9 -- The angiotensin-receptor blocker candesartan (Atacand) markedly reduced the risk of ... MedPage Today Candesartan therapy can reduce the risk of diabetes in heart failure ... - Jul 11, 2005 A reduction in the risk of developing diabetes has been shown in heart failure patients on candesartan cilexetil ("candesartan") therapy. ... Medical News Today - Medical News Today (press release) DRUG MAY DELAY HYPERTENSION IN HIGH-RISK PATIENTS - Apr 24, 2006 The researchers randomly assigned 800 patients with pre-hypertension to receive either a blood pressure medication called candesartan or a placebo for two ... $2.95 - Boston Globe - NewsBank Brand Names/Synonyms: Candesartan is also known by the following brand names and/or synonymsAtacand; Blopress; CHEMBANK1631; Candesartan; Candesartan [Usan:Inn]; Candesartan/Cilexetil Drug Category: Candesartan is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin II Receptor Antagonists; ATC:C09CA06 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-benzoimidazole-4-carboxylicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |